CTOs on the Move

Accolade

www.accolade.com

 
We`re the only on-demand healthcare concierge for employers, health plans and health systems. Join our customers who experience industry-leading engagement levels, satisfaction scores unseen in health care, better health outcomes, and substantial medical cost savings of more than 10 percent. Our team of compassionate, trusted professionals, supported by breakthrough science and technologies guide consumers through the healthcare system in a deeply personalized manner. We`ve been recognized as one of the nation`s 25 most promising companies by Forbes magazine, the fastest-growing private healthcare company by Inc. 500, and a top workplace by multiple news publications.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.accolade.com
  • 660 West Germantown Pike Suite 500
    Plymouth Meeting, PA USA 19462
  • Phone: 610.834.2989

Executives

Name Title Contact Details
John Visneski
Chief Information Security Officer Profile
Kelli Burns
Senior Vice President and Chief Information Security Officer Profile
Harish Naidu
Chief Technology Officer Profile

Funding

Accolade raised $16M on 12/09/2015
Accolade raised $50M on 03/29/2018
Accolade raised $20M on 10/10/2019

Similar Companies

Belmont Manor Nursing Home Inc

Belmont Manor Nursing Home Inc is a Belmont, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tom Bigbee Healthcare Authority

Tom Bigbee Healthcare Authority is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Demopolis, AL. To find more information about Tom Bigbee Healthcare Authority, please visit www.bwwmh.com

Stafford Suites

Stafford Suites is a Sumner, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Molecular Bio-Products

We deliver the industry's broadest selection of analytical instruments, equipment, consumables and laboratory supplies. Our growing portfolio of products includes innovative technologies for mass spectrometry, elemental analysis, molecular spectroscopy,

Cardionomic

Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.